Related Experiment Video
Updated: May 9, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Hypercoagulability in venous and arterial thrombosis
1University of North Carolina School of Medicine, Chapel Hill, USA.
Annals of Internal Medicine
|April 15, 1997
Summary
Hypercoagulability increases thrombosis risk due to genetic defects or acquired causes. Anticoagulant therapy is crucial for high-risk patients, with decisions individualized for recurrent or severe cases.
Area of Science:
- Hematology
- Cardiovascular Medicine
- Genetics
Background:
- Hypercoagulability describes an increased risk of thrombosis.
- Genetic defects in anticoagulant pathways affect approximately 20% of European patients with venous thromboembolism.
- Arterial thrombosis often results from atherosclerosis but involves hypercoagulability markers.
Purpose of the Study:
- To define hypercoagulability and its implications in thrombosis.
- To outline indications for anticoagulant prophylaxis and therapy.
- To explore the role of hemostatic markers in assessing cardiovascular disease risk.
Main Methods:
- Review of existing literature on hypercoagulability and thrombosis.
- Analysis of genetic defects in anticoagulant pathways.
- Evaluation of hemostatic markers in arterial thrombosis and coronary heart disease risk.
Main Results:
- Inherited defects in anticoagulant pathways are a significant cause of venous thromboembolism.
- Anticoagulant prophylaxis is recommended during high-risk periods, such as post-surgery.
- Elevated fibrinogen and factor VII activity are key markers in atherosclerosis-related hypercoagulability.
Conclusions:
- Hypercoagulability, whether inherited or acquired, necessitates careful management.
- Individualized assessment is key for prolonged anticoagulant therapy decisions.
- Hemostatic markers show promise in predicting coronary heart disease risk.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...